Amarin Corporation PLC (AMRN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: AMRN Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-01-24 2024-01-22 B Purchase

Holt Patrick

President and CEO

Executive Director
14,426 +4.8%
1.09
15,724 USD 		14,426 +4.8% 1.09 15,724 USD
2023-12-14 2023-12-12 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
34,131 -5.7%
0.79
26,963 USD 		34,131 -5.7% 0.79 26,963 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
67,222 +28.9%
1.06
71,255 USD 		67,222 +28.9% 1.06 71,255 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
25,845 +12.4%
1.06
27,266 USD 		25,845 +12.4% 1.06 27,266 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
12,700 +6.5%
1.05
13,335 USD 		12,700 +6.5% 1.05 13,335 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
30,642 +18.7%
1.04
31,868 USD 		30,642 +18.7% 1.04 31,868 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
19,358 +13.4%
1.04
20,036 USD 		19,358 +13.4% 1.04 20,036 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
143,275 +14955.6%
1.03
147,573 USD 		143,275 +14955.6% 1.03 147,573 USD
2023-08-16 2023-08-16 B Purchase

Holt Patrick

President and CEO

Executive Director
958 +inf%
1.03
982 USD 		958 +inf% 1.03 982 USD
2022-06-15 2022-06-13 B Purchase

WOLD OLSEN PER

Non-Executive Director
55,000 +58.5%
1.69
92,730 USD 		55,000 +58.5% 1.69 92,730 USD
2021-12-16 2021-12-15 B Purchase

Zakrzewski Joseph S

Non-Executive Director
2,000 +1.0%
3.16
6,310 USD 		2,000 +1.0% 3.16 6,310 USD
2021-12-16 2021-12-14 B Purchase

Zakrzewski Joseph S

Non-Executive Director
10,000 +5.4%
3.27
32,689 USD 		10,000 +5.4% 3.27 32,689 USD
2021-06-07 2021-06-04 B Purchase

STACK DAVID M

Non-Executive Director
10,000 +33.3%
4.54
45,350 USD 		10,000 +33.3% 4.54 45,350 USD
2021-06-07 2021-06-03 B Purchase

STACK DAVID M

Non-Executive Director
5,000 +20.0%
4.62
23,115 USD 		5,000 +20.0% 4.62 23,115 USD
2021-02-03 2021-02-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
25,370 -6.2%
8.03
203,670 USD 		25,370 -6.2% 8.03 203,670 USD
2021-02-03 2021-02-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
192,358 -32.0%
8.06
1,550,463 USD 		192,358 -32.0% 8.06 1,550,463 USD
2021-01-29 2021-01-27 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
143,392 -27.0%
8.01
1,149,258 USD 		143,392 -27.0% 8.01 1,149,258 USD
2021-01-29 2021-01-27 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
278,237 -34.4%
8.01
2,228,873 USD 		278,237 -34.4% 8.01 2,228,873 USD
2020-12-02 2020-11-30 B Purchase

STACK DAVID M

Non-Executive Director
25,000 +inf%
4.86
121,518 USD 		25,000 +inf% 4.86 121,518 USD
2020-11-12 2020-11-11 S Sale

THERO JOHN F

President and CEO

Executive Director
413,565 -13.1%
4.07
1,681,183 USD 		413,565 -13.1% 4.07 1,681,183 USD
2020-11-12 2020-11-10 S Sale

THERO JOHN F

President and CEO

Executive Director
153,840 -4.7%
4.13
635,975 USD 		153,840 -4.7% 4.13 635,975 USD
2020-03-06 2020-03-04 PS Planned sale

THERO JOHN F

President and CEO
200,000 -7.5%
15.99
3,198,700 USD 		200,000 -7.5% 15.99 3,198,700 USD
2020-01-03 2020-01-03 PS Planned sale

Zakrzewski Joseph S

300,000 -78.0%
20.94
6,282,870 USD 		300,000 -78.0% 20.94 6,282,870 USD
2019-12-18 2019-12-16 PS Planned sale

Zakrzewski Joseph S

Non-Executive Director
100,000 -54.2%
25.83
2,583,380 USD 		100,000 -54.2% 25.83 2,583,380 USD
2019-12-18 2019-12-16 PS Planned sale

Berg Aaron

CHIEF COMMERCIAL OFFICER

Officer
43,253 -24.4%
25.46
1,101,364 USD 		43,253 -24.4% 25.46 1,101,364 USD
2019-12-18 2019-12-16 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
100 -0.5%
25.66
2,566 USD 		100 -0.5% 25.66 2,566 USD
2019-12-18 2019-12-16 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
1,000 -4.4%
24.84
24,836 USD 		1,000 -4.4% 24.84 24,836 USD
2019-12-18 2019-12-16 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
7,500 -24.9%
23.81
178,586 USD 		7,500 -24.9% 23.81 178,586 USD
2019-12-18 2019-12-16 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
16,400 -35.2%
23.05
378,023 USD 		16,400 -35.2% 23.05 378,023 USD
2019-11-21 2019-11-19 PS Planned sale

THERO JOHN F

President and CEO

Executive Director
274,454 -10.5%
22.65
6,217,371 USD 		274,454 -10.5% 22.65 6,217,371 USD
2019-11-13 2019-11-12 PS Planned sale

Ekman Lars

Non-Executive Director
38,600 -100.0%
19.35
746,759 USD 		38,600 -100.0% 19.35 746,759 USD
2019-11-13 2019-11-11 PS Planned sale

THERO JOHN F

President and CEO

Executive Director
41,741 -1.6%
17.88
746,296 USD 		41,741 -1.6% 17.88 746,296 USD
2019-11-13 2019-11-11 PS Planned sale

THERO JOHN F

President and CEO

Executive Director
433,805 -14.0%
17.05
7,397,156 USD 		433,805 -14.0% 17.05 7,397,156 USD
2019-11-07 2019-11-05 PS Planned sale

Ekman Lars

6,400 -100.0%
18.00
115,230 USD 		6,400 -100.0% 18.00 115,230 USD
2019-09-05 2019-09-03 PS Planned sale

Ekman Lars

91,016 -100.0%
15.01
1,365,722 USD 		91,016 -100.0% 15.01 1,365,722 USD
2019-07-12 2019-07-11 PS Planned sale

STACK DAVID M

51,991 -100.0%
22.28
1,158,354 USD 		51,991 -100.0% 22.28 1,158,354 USD
2019-07-05 2019-07-05 PS Planned sale

Zakrzewski Joseph S

100,000 -54.2%
23.82
2,381,580 USD 		100,000 -54.2% 23.82 2,381,580 USD
2019-07-03 2019-07-03 PS Planned sale

Berg Aaron

CHIEF COMMERCIAL OFFICER
29,250 -44.6%
22.64
662,238 USD 		29,250 -44.6% 22.64 662,238 USD
2019-07-03 2019-07-02 PS Planned sale

Berg Aaron

CHIEF COMMERCIAL OFFICER
19,564 -35.0%
21.42
419,061 USD 		19,564 -35.0% 21.42 419,061 USD
2019-07-03 2019-07-02 PS Planned sale

Berg Aaron

CHIEF COMMERCIAL OFFICER
50,000 -47.2%
20.46
1,023,080 USD 		50,000 -47.2% 20.46 1,023,080 USD
2019-07-03 2019-07-01 PS Planned sale

Kennedy Joseph T

General Counsel
54,186 -63.4%
19.52
1,057,906 USD 		54,186 -63.4% 19.52 1,057,906 USD
2019-07-03 2019-07-01 PS Planned sale

Kalb Michael Wayne

SVP and CFO
50,000 -70.6%
19.67
983,270 USD 		50,000 -70.6% 19.67 983,270 USD
2019-06-26 2019-06-24 PS Planned sale

Berg Aaron

CHIEF COMMERCIAL OFFICER
113,195 -75.7%
18.59
2,104,521 USD 		113,195 -75.7% 18.59 2,104,521 USD
2019-06-20 2019-06-18 PS Planned sale

Zakrzewski Joseph S

100,000 -54.2%
19.02
1,902,090 USD 		100,000 -54.2% 19.02 1,902,090 USD
2019-05-31 2019-05-31 PS Planned sale

Kennedy Joseph T

General Counsel
27,229 -46.6%
17.92
488,058 USD 		27,229 -46.6% 17.92 488,058 USD
2019-05-31 2019-05-29 PS Planned sale

STACK DAVID M

Non-Executive Director
33,799 -100.0%
18.45
623,534 USD 		33,799 -100.0% 18.45 623,534 USD
2019-05-21 2019-05-17 PS Planned sale

STACK DAVID M

Non-Executive Director
13,174 -100.0%
18.00
237,139 USD 		13,174 -100.0% 18.00 237,139 USD
2019-05-02 2019-04-30 PS Planned sale

Kennedy Joseph T

General Counsel
27,230 -46.6%
18.69
508,839 USD 		27,230 -46.6% 18.69 508,839 USD
2019-05-02 2019-04-30 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.6%
18.67
178,107 USD 		9,541 -2.6% 18.67 178,107 USD
2019-04-01 2019-04-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer
100 -0.0%
20.78
2,078 USD 		100 -0.0% 20.78 2,078 USD
2019-04-01 2019-04-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer
9,442 -2.6%
20.05
189,314 USD 		9,442 -2.6% 20.05 189,314 USD
2019-04-01 2019-04-01 PS Planned sale

Kennedy Joseph T

General Counsel
53,060 -62.1%
20.03
1,062,993 USD 		53,060 -62.1% 20.03 1,062,993 USD
2019-03-06 2019-03-04 PS Planned sale

Ekman Lars

36,700 -100.0%
21.71
796,830 USD 		36,700 -100.0% 21.71 796,830 USD
2019-03-06 2019-03-04 PS Planned sale

Ekman Lars

98,677 -72.9%
21.16
2,088,074 USD 		98,677 -72.9% 21.16 2,088,074 USD
2019-03-06 2019-03-04 PS Planned sale

THERO JOHN F

President and CEO

Executive Director
70,673 -3.3%
21.70
1,533,894 USD 		70,673 -3.3% 21.70 1,533,894 USD
2019-03-06 2019-03-04 PS Planned sale

THERO JOHN F

President and CEO

Executive Director
179,327 -7.7%
21.15
3,793,340 USD 		179,327 -7.7% 21.15 3,793,340 USD
2019-03-01 2019-03-01 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
22,075 -51.8%
22.59
498,582 USD 		22,075 -51.8% 22.59 498,582 USD
2019-03-01 2019-03-01 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
70,801 -62.4%
22.06
1,561,721 USD 		70,801 -62.4% 22.06 1,561,721 USD
2019-03-01 2019-03-01 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
7,124 -5.9%
20.89
148,795 USD 		7,124 -5.9% 20.89 148,795 USD
2019-03-01 2019-03-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
7,099 -2.0%
22.64
160,717 USD 		7,099 -2.0% 22.64 160,717 USD
2019-03-01 2019-03-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
35,398 -8.9%
22.10
782,197 USD 		35,398 -8.9% 22.10 782,197 USD
2019-03-01 2019-03-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
3,503 -0.9%
20.94
73,361 USD 		3,503 -0.9% 20.94 73,361 USD
2019-03-01 2019-02-28 PS Planned sale

Kennedy Joseph T

General Counsel

Officer
27,231 -46.6%
20.72
564,172 USD 		27,231 -46.6% 20.72 564,172 USD
2019-03-01 2019-02-28 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
9,543 -2.6%
20.67
197,249 USD 		9,543 -2.6% 20.67 197,249 USD
2019-02-22 2019-02-22 PS Planned sale

Peterson Kristine

Non-Executive Director
163,500 -100.0%
20.02
3,274,038 USD 		163,500 -100.0% 20.02 3,274,038 USD
2019-02-22 2019-02-22 PS Planned sale

Zakrzewski Joseph S

Non-Executive Director
180,625 -68.1%
19.90
3,594,438 USD 		180,625 -68.1% 19.90 3,594,438 USD
2019-02-22 2019-02-22 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
50,000 -70.9%
18.97
948,500 USD 		50,000 -70.9% 18.97 948,500 USD
2019-02-22 2019-02-22 PS Planned sale

VAN HEEK G JAN

Non-Executive Director
203,382 -93.5%
20.02
4,071,423 USD 		203,382 -93.5% 20.02 4,071,423 USD
2019-02-15 2019-02-15 PS Planned sale

Kalb Michael Wayne

SVP and CFO

Officer
25,000 -54.9%
17.58
439,525 USD 		25,000 -54.9% 17.58 439,525 USD
2019-02-01 2019-02-01 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
27,989 -7.3%
17.06
477,498 USD 		27,989 -7.3% 17.06 477,498 USD
2019-02-01 2019-01-31 PS Planned sale

Kennedy Joseph T

General Counsel

Officer
42,624 -57.7%
17.49
745,468 USD 		42,624 -57.7% 17.49 745,468 USD
2019-02-01 2019-01-31 PS Planned sale

Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.7%
17.49
166,875 USD 		9,541 -2.7% 17.49 166,875 USD
2019-01-24 2019-01-24 PS Planned sale

Kennedy Joseph T

General Counsel

Officer
609,115 -100.0%
17.66
10,754,717 USD 		609,115 -100.0% 17.66 10,754,717 USD
2019-01-24 2019-01-23 PS Planned sale

Kennedy Joseph T

General Counsel

Officer
255,779 -54.0%
17.95
4,591,310 USD 		255,779 -54.0% 17.95 4,591,310 USD
2019-01-24 2019-01-22 PS Planned sale

Kennedy Joseph T

General Counsel

Officer
175,300 -44.6%
17.92
3,141,884 USD 		175,300 -44.6% 17.92 3,141,884 USD